Role of resveratrol in the management of insulin resistance and related conditions: Mechanism of action (Q39432694)

11 September 2017

Role of resveratrol in the management of insulin resistance and related conditions: Mechanism of action (English)

1 reference

11 September 2017

1 reference

Ebrahim Abbasi Oshaghi

1

1 reference

11 September 2017

Mohammad Taghi Goodarzi

2

1 reference

11 September 2017

Victoria Higgins

3

1 reference

11 September 2017

Khosrow Adeli

4

1 reference

11 September 2017

13 July 2017

1 reference

Critical Reviews in Clinical Laboratory Sciences

11 September 2017

27

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

11 September 2017

54

1 reference

11 September 2017

4

1 reference

11 September 2017

267-293

1 reference

Global burden of obesity in 2005 and projections to 2030.

11 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Mechanisms of obesity-associated insulin resistance: many choices on the menu

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Global estimates of diabetes prevalence for 2013 and projections for 2035.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Lipoprotein metabolism in obesity and diabetes: insights from stable isotope kinetic studies in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Insulin resistance is central to the burden of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Anti-diabetic effects of resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol and obesity: Can resveratrol relieve metabolic disturbances?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol: anti-obesity mechanisms of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

The study of phenolic compounds as natural antioxidants in wine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Plant polyphenols as dietary antioxidants in human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Polyphenols and health: update and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol: review on therapeutic potential and recent advances in drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Multiplicity of effects and health benefits of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Localization of stilbene synthase in Vitis vinifera L. during berry development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Whole-body insulin sensitivity, low-density lipoprotein (LDL) particle size, and oxidized LDL in overweight, nondiabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

A stilbene synthase gene (SbSTS1) is involved in host and nonhost defense responses in sorghum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol: a molecule whose time has come? And gone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol as an anticancer nutrient: molecular basis, open questions and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol: How Much Wine Do You Have to Drink to Stay Healthy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

The bioavailability and distribution of trans-resveratrol are constrained by ABC transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Enhancing the delivery of resveratrol in humans: if low bioavailability is the problem, what is the solution?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

High absorption but very low bioavailability of oral resveratrol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Efficient methodologies for system matrix modelling in iterative image reconstruction for rotating high-resolution PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol in cardiovascular disease: what is known from current research?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Therapeutic potential of resveratrol: the in vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Dose-dependency of resveratrol in providing health benefits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Dietary polyphenols and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Toxicogenomics of resveratrol in rat liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol-associated renal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Safety studies conducted on high-purity trans-resveratrol in experimental animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

What is new for resveratrol? Is a new set of recommendations necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Diagnostic performance of urinary resveratrol metabolites as a biomarker of moderate wine consumption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol and diabetes: from animal to human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Wines and grape juices as modulators of platelet aggregation in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Conjugated linoleic acid-mediated inflammation and insulin resistance in human adipocytes are attenuated by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Hypoglycemic effect of resveratrol in type 2 diabetic model db/db mice and its actions in cultured L6 myotubes and RIN-5F pancreatic β-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

A new insight into resveratrol as an atheroprotective compound: inhibition of lipid peroxidation and enhancement of cholesterol efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol and health--a comprehensive review of human clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

SIRT1 transgenic mice show phenotypes resembling calorie restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol bioavailability and toxicity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

The pharmacology of resveratrol in animals and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Effect of resveratrol on fat mobilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Anti-atherogenic effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol and liver: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Hepatic mitochondrial and ER stress induced by defective PPARα signaling in the pathogenesis of hepatic steatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Insulin resistance is a cellular antioxidant defense mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Overexpression of manganese superoxide dismutase ameliorates high-fat diet-induced insulin resistance in rat skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Skeletal muscle lipid peroxidation and insulin resistance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Oxidative stress and the etiology of insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Free fatty acid-induced muscle insulin resistance and glucose uptake dysfunction: evidence for PKC activation and oxidative stress-activated signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Inhibition of protein kinase C by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Cellular mechanisms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Development of glucose-induced insulin resistance in muscle requires protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Improved Glucose Homeostasis in Obese Mice Treated With Resveratrol Is Associated With Alterations in the Gut Microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Pilot study of resveratrol in older adults with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Sirtuin 1 and sirtuin 3: physiological modulators of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Activation of SIRT3 by resveratrol ameliorates cardiac fibrosis and improves cardiac function via the TGF-β/Smad3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol is not a direct activator of SIRT1 enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Inhibition of PTP1B restores IRS1-mediated hepatic insulin signaling in IRS2-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Evaluation of anti-hyperglycemic and hypoglycemic effect of Trigonella foenum-graecum Linn, Ocimum sanctum Linn and Pterocarpus marsupium Linn in normal and alloxanized diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Effects of resveratrol on obesity-related inflammation markers in adipose tissue of genetically obese rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Effects of resveratrol on the insulin signaling pathway of obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Insulin resistance due to nutrient excess: is it a consequence of AMPK downregulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Insulin inhibition of apolipoprotein B mRNA translation is mediated via the PI-3 kinase/mTOR signaling cascade but does not involve internal ribosomal entry site (IRES) initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Mechanisms of beta-cell death in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Inhibition of insulin secretion as a new drug target in the treatment of metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Etiology of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Interleukin-6 induces cellular insulin resistance in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

The insulin-suppressive effect of resveratrol - an in vitro and in vivo phenomenon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Inhibition of IAPP Aggregation and Toxicity by Natural Products and Derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Protein folding and aggregation into amyloid: the interference by natural phenolic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Mutational analysis of the ability of resveratrol to inhibit amyloid formation by islet amyloid polypeptide: critical evaluation of the importance of aromatic-inhibitor and histidine-inhibitor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol inhibits the formation of multiple-layered β-sheet oligomers of the human islet amyloid polypeptide segment 22-27

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol prevents interleukin-1β-induced dysfunction of pancreatic β-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Pioglitazone and sodium salicylate protect human beta-cells against apoptosis and impaired function induced by glucose and interleukin-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Activation of the GLP-1 receptor signalling pathway: a relevant strategy to repair a deficient beta-cell mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Diabetes and beta cell function: from mechanisms to evaluation and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Glucagon-like peptide-1 as a key regulator of lipid and lipoprotein metabolism in fasting and postprandial states

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Incretin-based therapies for treatment of postprandial dyslipidemia in insulin-resistant states

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Gut Peptides Are Novel Regulators of Intestinal Lipoprotein Secretion: Experimental and Pharmacological Manipulation of Lipoprotein Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol and curcumin enhance pancreatic β-cell function by inhibiting phosphodiesterase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Nkx6.1 is essential for maintaining the functional state of pancreatic beta cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Up-regulation of adiponectin by resveratrol: the essential roles of the Akt/FOXO1 and AMP-activated protein kinase signaling pathways and DsbA-L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Fructose, insulin resistance, and metabolic dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Dietary fructose and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Fructose-mediated stress signaling in the liver: implications for hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian golden hamster

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Treatment with atorvastatin ameliorates hepatic very-low-density lipoprotein overproduction in an animal model of insulin resistance, the fructose-fed Syrian golden hamster: evidence that reduced hypertriglyceridemia is accompanied by improved hepat

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Tumor necrosis factor-alpha induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Mechanisms of insulin resistance in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol prevents high-fructose corn syrup-induced vascular insulin resistance and dysfunction in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol decreases fructose-induced oxidative stress, mediated by NADPH oxidase via an AMPK-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Dietary Fructose Activates Insulin Signaling and Inflammation in Adipose Tissue: Modulatory Role of Resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Relationship between insulin resistance and partially oxidized LDL particles in healthy, nondiabetic volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Relation of circulating oxidized LDL to obesity and insulin resistance in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Oxidative stress and insulin resistance: the coronary artery risk development in young adults study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Targeting oxidized LDL improves insulin sensitivity and immune cell function in obese Rhesus macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Hypertriglyceridemia, insulin resistance, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Role of insulin signaling impairment, adiponectin and dyslipidemia in peripheral and central neuropathy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol toxicity: effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Insulin silences apolipoprotein B mRNA translation by inducing intracellular traffic into cytoplasmic RNA granules

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Hypertriglyceridemia: Cause or Consequence of Insulin Resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Construction of cDNA library from human colorectal cancer cell HRT-18

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

A Hamster Model of Diet-Induced Obesity for Preclinical Evaluation of Anti-Obesity, Anti-Diabetic and Lipid Modulating Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Diabetes contributes to cholesterol metabolism regardless of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Cerivastatin improves insulin sensitivity and insulin secretion in early-state obese type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol inhibits fatty acid and triacylglycerol synthesis in rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Antiobesity and vasoprotective effects of resveratrol in apoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

CETP inhibitors to increase HDL cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Effects of torcetrapib in patients at high risk for coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Isolated low HDL cholesterol. An insulin-resistant state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

New insights into the regulation of HDL metabolism and reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol regulates the expression of LXR-alpha in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

The influence of moderate red wine consumption on antioxidant status and indices of oxidative stress associated with CHD in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Association of scavenger receptors in adipose tissue with insulin resistance in nondiabetic humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

The dietary antioxidant resveratrol affects redox changes of PPARalpha activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

The Role of Anethum graveolens L. (Dill) in the Management of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol-Dependent Down-regulation of Receptor for Advanced Glycation End-products and Oxidative Stress in Kidney of Rats With Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Effect of resveratrol on resistin and apelin gene expressions in adipose tissue of diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Adipocyte lipolysis and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Secretion of fatty acid binding protein aP2 from adipocytes through a nonclassical pathway in response to adipocyte lipase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Changes in white adipose tissue metabolism induced by resveratrol in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Glucose-6-Phosphate Dehydrogenase Deficiency Improves Insulin Resistance With Reduced Adipose Tissue Inflammation in Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Increased diacylglycerol acyltransferase activity is associated with triglyceride accumulation in tissues of diet-induced insulin-resistant hyperlipidemic hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Insulin regulates hepatic apolipoprotein B production independent of the mass or activity of Akt1/PKBalpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Hepatic regulation of apolipoprotein B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol inhibits LXRα-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Stearoyl-CoA desaturase-1 is associated with insulin resistance in morbidly obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Skeletal muscle insulin resistance: roles of fatty acid metabolism and exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol attenuates mitochondrial dysfunction in the liver of intrauterine growth retarded suckling piglets by improving mitochondrial biogenesis and redox status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Effects of L-carnitine on growth performance, carcass composition, and metabolism of lipids in male broilers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Gut microbiota: the next-gen frontier in preventive and therapeutic medicine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Metabolic endotoxemia initiates obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Effect of probiotics Lactobacillus and Bifidobacterium on gut-derived lipopolysaccharides and inflammatory cytokines: an in vitro study using a human colonic microbiota model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Oral administration of Bifidobacterium spp. improves insulin resistance, induces adiponectin, and prevents inflammatory adipokine expressions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

The anti-diabetic activity of Bifidobacterium lactis HY8101 in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Bifidobacterium CECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

A European Competence Framework for Industrial Pharmacy Practice in Biotechnology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Effect of a low dose of dietary resveratrol on colon microbiota, inflammation and tissue damage in a DSS-induced colitis rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Propensity to high-fat diet-induced obesity in mice is associated with the indigenous opportunistic bacteria on the interior of Peyer's patches

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Replication of obesity and associated signaling pathways through transfer of microbiota from obese-prone rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Chronic Repression of mTOR Complex 2 Induces Changes in the Gut Microbiota of Diet-induced Obese Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

LPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by Resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Chemoprevention in experimental animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol Protects Oxidative Stress-Induced Intestinal Epithelial Barrier Dysfunction by Upregulating Heme Oxygenase-1 Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Protective Capacity of Resveratrol, a Natural Polyphenolic Compound, against Deoxynivalenol-Induced Intestinal Barrier Dysfunction and Bacterial Translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Benefits of polyphenols on gut microbiota and implications in human health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Plasma and urine metabolic profiles are reflective of altered beta-oxidation in non-diabetic obese subjects and patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Effects of Resveratrol on Receptor for Advanced Glycation End Products (RAGE) Expression and Oxidative Stress in the Liver of Rats with Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

Resveratrol Is Absorbed in the Small Intestine as Resveratrol Glucuronide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408363.2017.1343274

10.1080/10408363.2017.1343274

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference